Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c02624 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Qiuyue Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 201 Literaturangaben. Gefördert von: China Association for Science and Technology, State Key Laboratory of Natural Medicines, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Abnormal phosphorylation of proteins can lead to various diseases, particularly cancer. Therefore, the development of small molecules for precise regulation of protein phosphorylation holds great potential for drug design. While the traditional kinase/phosphatase small-molecule modulators have shown some success, achieving precise phosphorylation regulation has proven to be challenging. The emergence of heterobifunctional molecules, such as phosphorylation-inducing chimeric small molecules (PHICSs) and phosphatase recruiting chimeras (PHORCs), with proximity-inducing modalities is expected to lead to a breakthrough by specifically recruiting kinase or phosphatase to the protein of interest. Herein, we summarize the drug targets with aberrant phosphorylation in cancer and underscore the potential of correcting phosphorylation in cancer therapy. Through reported cases of heterobifunctional molecules targeting phosphorylation regulation, we highlight the current design strategies and features of these molecules. We also provide a systematic elaboration of the link between aberrantly phosphorylated targets and cancer as well as the existing challenges and future research directions for developing heterobifunctional molecular drugs for phosphorylation regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.
- Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
ORCID-Profile: Qidong You, Lei Wang
Förderung
- China Association for Science and Technology
- State Key Laboratory of Natural Medicines
- China Postdoctoral Science Foundation
- Natural Science Foundation of Jiangsu Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Funding Program for Excellent Postdoctoral Talent
Zitieren
APA
Zhang, Q., Yu, J., You, Q., & Wang, L. (2024). Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c02624
Vancouver
Zhang Q, Yu J, You Q, Wang L. Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c02624
BibTeX
@article{Zhang2024,
author = {Zhang, Qiuyue and Yu, Jia and You, Qidong and Wang, Lei},
title = {Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c02624}
}
EUVIMED